In addition, FAM111B gene has been proven to be a reliable signature for predicting HCC response to transarterial chemoembolization (TACE) [20], and it can also be used to anticipate distal metastasis in patients with cervical cancer [21]. This evidence concerns the gene FAM111B and hepatocellular carcinoma.